Hip Replacement Implants Market by Product Type (Total Hip Replacement Implants, Partial Hip Replacement Implants, Hip Resurfacing Implants), by Material (Metal-on-Metal, Metal-on-Polyethylene, Ceramic-on-Polyethylene, Ceramic-on-Ceramic, Ceramic-on-Metal), by Approach (Posterior Approach, Anterior Approach, Lateral Approach), by End-User (Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers), and by Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Hip Replacement Implants Market was valued at USD 8.2 Billion in 2024-e and will surpass USD 9.6 Billion by 2030; growing at a CAGR of 2.7% during 2025-2030.

The hip replacement implants market has seen steady growth in recent years, driven by the increasing prevalence of hip-related disorders, particularly in the aging population. Hip replacement surgery is commonly performed to address conditions such as osteoarthritis, fractures, and degenerative diseases, with patients benefiting from improved mobility and reduced pain. Advances in implant technologies and surgical techniques, along with a rising demand for minimally invasive procedures, are key factors contributing to the expansion of this market. As the global healthcare infrastructure improves and more patients opt for hip replacement surgery, the market is expected to continue its upward trajectory.

Total Hip Replacement Implants Segment is Largest Owing to Widespread Adoption

The total hip replacement (THR) implants segment holds the largest market share within the hip replacement implants sector. This is due to the fact that total hip replacement is often the go-to solution for patients suffering from severe hip arthritis or fractures. Total hip replacement involves the complete removal of the damaged bone and cartilage and replacing them with a prosthetic joint, offering long-lasting and effective relief from pain and mobility issues. With a high success rate and better overall outcomes, THR is widely favored, especially for patients over the age of 60, making it the most preferred procedure in hip replacement surgeries globally.

The growing number of elderly people suffering from conditions such as osteoarthritis and the increasing number of hip injuries in active adults contribute to the demand for total hip replacements. Moreover, advancements in implant designs, such as the development of ceramic and metal combinations, are helping improve the durability and longevity of these implants, making THR an even more viable option for patients. As a result, the total hip replacement implants segment is expected to continue its dominance throughout the forecast period.

Ceramic-on-Polyethylene Material is Fastest Growing Owing to Superior Wear Resistance

The ceramic-on-polyethylene material segment is experiencing the fastest growth within the hip replacement implants market. This material combination offers several advantages over traditional metal-on-polyethylene implants, particularly in terms of wear resistance and longevity. Ceramic materials, known for their smooth surface, significantly reduce friction, which in turn minimizes wear and tear over time. This makes ceramic-on-polyethylene implants particularly suitable for younger, more active patients who require a durable solution for hip replacement.

As advancements in materials technology continue, ceramic-on-polyethylene implants are becoming more popular due to their reduced risk of complications, such as implant failure or dislocation, and their ability to offer a longer-lasting solution. This growing preference among patients and orthopedic surgeons alike is expected to further fuel the expansion of this segment in the coming years. Additionally, the development of more cost-effective ceramic materials is helping to increase the accessibility of this solution.

Posterior Approach is Largest Owing to Minimal Surgical Complications

The posterior approach remains the most widely used surgical technique for hip replacement procedures, contributing to its large share in the market. The posterior approach involves making an incision at the back of the hip, providing direct access to the joint, and allowing for precise positioning of the implant. This method has been favored for its ability to achieve accurate joint alignment and restore the natural range of motion in patients.

One of the key advantages of the posterior approach is that it generally results in fewer complications, such as nerve damage or hip dislocation, compared to other approaches. This has made it a preferred choice among orthopedic surgeons for total hip replacement surgeries. With ongoing improvements in surgical tools and techniques, the posterior approach is expected to remain dominant in the global hip replacement implants market.

Hospitals Segment is Largest Owing to High Patient Volume

The hospitals segment holds the largest share in the end-user category for hip replacement implants, largely due to the high volume of patients requiring hip replacement surgery. Hospitals are typically equipped with advanced diagnostic and surgical equipment, as well as specialized orthopedic departments, which make them the preferred setting for complex surgeries like hip replacements. Additionally, hospitals often serve as the first point of contact for patients requiring hip surgery, further driving the demand for implants in this sector.

Given the increasing number of surgeries performed in hospital settings, hospitals continue to be the primary end-user in the hip replacement implants market. Furthermore, hospitals are increasingly focusing on expanding their orthopedic surgery departments, which is expected to further boost the demand for hip replacement implants in the coming years.

North America Region is Largest Owing to Advanced Healthcare Infrastructure

North America holds the largest share in the global hip replacement implants market, driven by the region’s advanced healthcare infrastructure, higher healthcare spending, and growing awareness of orthopedic surgeries. The region’s high prevalence of osteoarthritis and hip-related injuries among its aging population has contributed to the growing demand for hip replacement implants. Moreover, North America is home to leading players in the orthopedic implant industry, further boosting the market in the region.

The United States, in particular, is expected to continue being a major contributor to the growth of the market due to its large elderly population, advancements in medical technology, and high healthcare standards. Additionally, the availability of highly skilled surgeons and access to state-of-the-art surgical facilities are other factors contributing to the region's leadership in the hip replacement implants market.

Competitive Landscape and Leading Companies

The global hip replacement implants market is highly competitive, with several key players striving to gain market share through innovation, strategic acquisitions, and product launches. Leading companies in the market include Johnson & Johnson (DePuy Synthes), Stryker Corporation, Zimmer Biomet, Smith & Nephew, and Medtronic. These companies dominate the market by offering a wide range of implants with varying material compositions and surgical approaches, catering to diverse patient needs.

The competitive landscape is marked by ongoing efforts to improve implant longevity, reduce complication rates, and develop more cost-effective solutions for hip replacement surgeries. Additionally, the increasing trend of minimally invasive surgeries and the demand for personalized implants have encouraged companies to focus on product differentiation through research and development. As the market grows, partnerships, mergers, and acquisitions are also expected to play a significant role in shaping the future of the hip replacement implants industry.

List of Leading Companies:

• Johnson & Johnson (DePuy Synthes)
• Stryker Corporation
• Zimmer Biomet
• Smith & Nephew
• Medtronic
• B. Braun Melsungen AG
• Exactech, Inc.
• MicroPort Scientific Corporation
• Arthrex, Inc.
• Stanmore Implants Worldwide Ltd
• Aesculap Implant Systems
• DJO Global, Inc.
• Limacorporate S.p.A.
• ConforMIS, Inc.
• Wright Medical Group N.V.

Recent Developments:

• Stryker announced the launch of their new Trident II Acetabular System, designed to provide better performance and durability for hip replacement patients.
• Zimmer Biomet acquired Amedica Corporation, gaining access to innovative ceramic technologies for hip implants, which aim to improve implant longevity and reduce wear.
• Medtronic received FDA approval for their Midas™ Hip System, a new implant system focusing on improved mobility and reducing recovery time for hip replacement patients.
• Smith & Nephew launched a new Legion™ Hip System, incorporating advanced materials and enhanced surgical techniques for better outcomes in hip replacement surgeries.
• Johnson & Johnson expanded their portfolio with the introduction of Vanguard® Revision Hip System, designed specifically for patients undergoing revision surgeries with more complex needs.

Report Scope: